1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,920 | 2,070 | 17:23 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | Q-Linea AB: Q-linea signs first distribution agreement in South Asia | 407 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA today announces the signing of its first distribution agreement in South Asia, marking an important milestone in the company's global expansion strategy. The agreement... ► Artikel lesen | |
| 23.12.25 | Q-Linea AB: Q-linea announces first two US hospital systems' clinical implementation of ASTar | 201 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces the clinical implementation of the first US ASTar instruments at UI (University of Iowa) Health Care and a large healthcare system in Texas. UI Health Care... ► Artikel lesen | |
| 20.11.25 | Q-Linea AB: Q-linea announces new organisation and changes in executive leadership team | 352 | GlobeNewswire (Europe) | Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) today announces that it has reached agreement with all relevant unions regarding the company's new organisation. As part of these changes, Ylva Molin has... ► Artikel lesen | |
| Q-LINEA Aktie jetzt für 0€ handeln | |||||
| 18.11.25 | Q-Linea AB: Q-linea announces FDA submission for expanded claims for ASTar BC G- panel | 647 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces their FDA 510(k) submission for expanded organism and antimicrobial claims on their ASTar BC G- panel, improving the clinical utility of the panel for... ► Artikel lesen | |
| 11.11.25 | Q-Linea AB: Q-linea announces outcome of rights issue | 208 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the outcome of the Company's rights issue of approximately SEK 322 (the "Rights Issue"), for which the subscription... ► Artikel lesen | |
| 24.10.25 | Listing of subscription rights and paid subscription shares of Q-Linea AB | 333 | GlobeNewswire | With effect from October 27, 2025, the subscription rights of Q-Linea AB will be traded on the list for Equity rights. Trading will continue up until and including November 05, 2025.
Instrument:
Subscription... ► Artikel lesen | |
| 22.10.25 | Q-Linea AB: Q-linea announces cost efficiency program to accelerate sales and marketing activities | 236 | GlobeNewswire (Europe) | Driven by Q-linea's strong commercial progression with a growing customer base, Q-linea today announced a cost efficiency program to optimise the organisation and cost structure to meet the increasing... ► Artikel lesen | |
| 21.10.25 | Q-Linea AB: Bulletin from Extraordinary General Meeting in Q-Linea AB (publ) | 218 | GlobeNewswire (Europe) | The extraordinary general meeting of Q-linea AB (publ) (the "Company"), org.nr. 556729-0217, was held on October 21, 2025 in Uppsala, Sweden, at which the shareholders primarily resolved as follows.... ► Artikel lesen | |
| 21.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 21.10.2025 | 298 | Xetra Newsboard | Das Instrument 3F80 SE0025420714 Q-LINEA AB EQUITY wird cum Kapitalmassnahme gehandelt am 21.10.2025 und ex Kapitalmassnahme am 22.10.2025 The instrument 3F80 SE0025420714 Q-LINEA AB EQUITY is traded... ► Artikel lesen | |
| 20.10.25 | Earnings Call Transkript: Q-linea erzielt starkes Wachstum bei wiederkehrenden Einnahmen im 3. Quartal 2025 | 3 | Investing.com Deutsch | ||
| 20.10.25 | Q-linea Q3 2025: Rekordnachfrage bei Verbrauchsmaterialien treibt globale Expansion an | 4 | Investing.com Deutsch | ||
| 20.10.25 | Q-Linea AB: Interim report 1 January - 30 September 2025 | 223 | GlobeNewswire (Europe) | Strong pipeline growth while the installed base of ASTar increases demand for consumables
The quarter July - September 2025Net sales amounted to SEK 3.5 (0.6) million.Operating result (EBIT) of SEK... ► Artikel lesen | |
| 19.10.25 | Q-Linea AB: Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-linea AB | 210 | GlobeNewswire (Europe) | The board of directors of Q-linea AB (publ) has today appointed Stuart Gander as CEO of the company. Former CEO Anders Ljunggren continues as deputy CEO of the company.
Since March 1, 2024, Stuart Gander... ► Artikel lesen | |
| 03.10.25 | Q-Linea AB: US Trauma Center signs commercial contract | 340 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) announces adoption of the first Accelerate Pheno conversion to the ASTar system by a prominent US level 1 University Hospital Trauma Center.
The University hospital selected... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea | Letter from the CEO | 263 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company update.
Key messagesReiterating target of 30 - 40 ASTar units contracted by end of year 2025 with outlook for 100 - 120 by end of 2026 and exceeding... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea resolves to carry out a rights issue of approximately SEK 322 million and announces terms | 347 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA), announces that the board of directors today has resolved to carry out a share issue of approximately SEK 322 million with preferential... ► Artikel lesen | |
| 05.09.25 | Q-Linea AB: Q-linea to initiate new clinical evaluations of ASTar in the GCC region | 474 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces 2 new clinical evaluations of ASTar in Saudi Arabia and Kuwait.
Q-linea, through the distributor partner AMICO Group, is moving into clinical evaluation of... ► Artikel lesen | |
| 14.07.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025 | 702 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025
Aktien
1 PLK2ITR00010 Fabrity S.A.
2 SE0013512506... ► Artikel lesen | |
| 11.07.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.07.2025 | 679 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.07.2025ISIN NameCA1394811055 CAPE... ► Artikel lesen | |
| 11.07.25 | XFRA ISIN CHANGE | 549 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,260 | -1,32 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,020 | -1,59 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,320 | +0,81 % | EILMELDUNG bei Carl Zeiss Meditec: Das Warnsignal das die meisten Anleger jetzt übersehen - Was ich konkret unternommen habe | ||
| DRAEGERWERK | 96,00 | -1,03 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| INTUITIVE SURGICAL | 398,45 | +0,56 % | The Silver Tsunami Is Here -- and Intuitive Surgical Could Be the Biggest Winner | ||
| MEDTRONIC | 73,48 | -1,66 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| THERMO FISHER | 448,00 | +0,16 % | TD Cowen lowers Thermo Fisher stock price target on valuation reset | ||
| TELADOC HEALTH | 4,668 | +4,95 % | Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc. | DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management:
Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY... ► Artikel lesen | |
| ROKU | 92,27 | +2,13 % | Research: Roku, Amazon TV OS gaining influence in US homes | ||
| HIMS & HERS HEALTH | 18,650 | +2,81 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,114 | +3,18 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherapeutics Inc. (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative... ► Artikel lesen | |
| DEXCOM | 53,60 | +0,37 % | DexCom, Inc.: Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 | New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren't on insulin therapy1 reinforcing the need to... ► Artikel lesen | |
| ALCON | 68,66 | +0,35 % | Bernstein SocGen reiterates Alcon stock rating on dry eye outlook | ||
| SIEMENS HEALTHINEERS | 38,390 | +0,26 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| ECKERT & ZIEGLER | 15,700 | 0,00 % | Eckert & Ziegler erhält MDR-Zertifizierung für Augentumorbehandlung | Die Eckert & Ziegler BEBIG GmbH, eine auf Brachytherapie spezialisierte Tochtergesellschaft der Eckert & Ziegler SE, hat die MDR-Zertifizierung der EU für ihre Ruthenium-106-Augenapplikatoren erhalten.... ► Artikel lesen |
Das Unternehmen Q-LINEA AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu Q-LINEA AB finden Sie auf Wallstreet Online.